Zepp Health (NYSE:ZEPP) Given a $56.28 Price Target by Fundamental Research Analysts

Zepp Health (NYSE:ZEPP) received a $56.28 price objective from analysts at Fundamental Research in a report released on Wednesday,BayStreet.CA reports. The brokerage presently has a “buy” rating on the stock. Fundamental Research’s target price points to a potential upside of 241.61% from the stock’s current price.

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of Zepp Health in a report on Wednesday, January 21st. One equities research analyst has rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, Zepp Health currently has a consensus rating of “Hold” and an average target price of $56.28.

Zepp Health Stock Down 0.1%

Shares of ZEPP opened at $16.48 on Wednesday. The firm has a market cap of $238.89 million, a PE ratio of -6.56 and a beta of 1.76. The company’s fifty day moving average is $16.80 and its two-hundred day moving average is $26.02. Zepp Health has a fifty-two week low of $2.22 and a fifty-two week high of $61.85. The company has a quick ratio of 0.77, a current ratio of 1.02 and a debt-to-equity ratio of 0.28.

Hedge Funds Weigh In On Zepp Health

A number of institutional investors have recently added to or reduced their stakes in ZEPP. FIL Ltd acquired a new position in Zepp Health in the 4th quarter worth $16,858,000. Trivest Advisors Ltd acquired a new position in Zepp Health in the 3rd quarter worth $13,503,000. Millennium Management LLC acquired a new position in Zepp Health in the 3rd quarter worth $11,265,000. UBS Group AG lifted its holdings in Zepp Health by 16,412.0% in the 3rd quarter. UBS Group AG now owns 181,302 shares of the company’s stock worth $8,300,000 after buying an additional 180,204 shares in the last quarter. Finally, Monolith Management Ltd acquired a new position in Zepp Health in the 4th quarter worth $3,601,000. Institutional investors and hedge funds own 52.61% of the company’s stock.

About Zepp Health

Zepp Health Corp is a technology company specializing in the design, development and sale of smart wearable devices and health management solutions. Through its flagship Amazfit brand and the Zepp software ecosystem, the company offers a range of products—including smartwatches, fitness bands, smart scales and health-oriented mobile applications—designed to track key biometric data such as heart rate, sleep patterns, blood oxygen levels and activity metrics. Zepp Health’s integrated platform enables users to monitor wellness and fitness goals while leveraging cloud-based analytics for personalized insights.

At the core of Zepp Health’s offering is its Zepp cloud platform, which aggregates and analyzes data collected from its hardware lineup.